Business & Industry
- Novartis enters agreement to acquire Mariana Oncology, strengthening radioligand therapy pipeline
- U.S. FDA approves Pfizer's BEQVEZ™ (fidanacogene elaparvovec-dzkt), a one-time gene therapy for adults with Hemophilia B
- AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in congestive heart failure
- European Commission approves Pfizer's EMBLAVEO® for patients with multidrug-resistant infections and limited treatment options
- AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson's disease
Research & Development
- Scientists pinpoint new vaccine "booster" that promotes potent anti-tumour immunity
- New treatment could reverse hair loss caused by an autoimmune skin disease
- AI predicts tumor-killing cells with high accuracy
- Participants of pioneering CRISPR gene editing trial see vision improve
- Drug targeting RNA modifications shows promise for treating neuroblastoma
- Scientists track 'doubling' in origin of cancer cells
- Possible alternative to antibiotics produced by bacteria
Conferences & Events
- SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
- SAE Media Group's 6th annual 3D Cell Culture Conference
- CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
- 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
- CPHI Excellence in Pharma Award Winners 2022
- CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
- CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index
Regulatory Affairs
- FDA approves nonsteroidal treatment for Duchenne muscular dystrophy
- FDA approves first gene therapies to treat patients with sickle cell disease
- FDA approves first therapy for rare type of non-cancerous tumors
- First electronic product information (ePI) published for selected human medicines
- FDA approves first treatment for patients with rare inherited blood clotting disorder